NCT05813665 2023-04-19A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of BoneShanghai JMT-Bio Inc.Phase 3 Not yet recruiting146 enrolled